HomeTLT • CVE
add
Theralase Technologies Inc
Previous close
$0.20
Day range
$0.19 - $0.19
Year range
$0.14 - $0.31
Market cap
41.28M CAD
Avg Volume
186.06K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 175.55K | -15.26% |
Operating expense | 1.34M | -11.42% |
Net income | -1.27M | 10.10% |
Net profit margin | -721.55 | -6.09% |
Earnings per share | — | — |
EBITDA | -1.23M | 10.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 114.41K | -68.73% |
Total assets | 3.25M | 1.41% |
Total liabilities | 1.28M | -5.56% |
Total equity | 1.97M | — |
Shares outstanding | 239.30M | — |
Price to book | 19.50 | — |
Return on assets | -97.60% | — |
Return on capital | -137.60% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.27M | 10.10% |
Cash from operations | -1.09M | 1.55% |
Cash from investing | -3.58K | 69.87% |
Cash from financing | 1.17M | 5,430.70% |
Net change in cash | 70.50K | 106.17% |
Free cash flow | -636.17K | -20.91% |
About
Founded
1989
Headquarters
Website
Employees
20